ISDA

Entry Detail

PDB ID:

8W13

Keywords:

Title:

Crystal structure of MYST acetyltransferase domain in complex with N-(1-(5-bromo-2-methoxyphenyl)-1H-1,2,3-triazol-4-yl)-2-methoxybenzenesulfonamide

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli BL21(DE3)

PDB Version:

Deposition Date:

2024-02-15

Release Date:

2024-09-11

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.81 Å

R-Value Free:

0.20

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Histone acetyltransferase KAT8
Chain IDs:A
Chain Length:278
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q9H7Z6 Pfam ID:PF17772, PF01853 EC:2.3.1.48

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
ALY	A	LYS	modified residue

Ligand Molecules

A1AEW

EDO

Primary Citation

Identification of triazolyl KAT6 inhibitors via a templated fragment approach.

Chen, C, Pawley, S.B, Cote, J.M, Carter, J, Wang, M, Xu, C, Buesking, A.W.Show

Bioorg.Med.Chem.Lett. 113 129948 129948 (2024)

PMID: 39236793 DOI: 10.1016/j.bmcl.2024.129948

Abstact

KAT6, a histone acetyltransferase from the MYST family, has emerged as an attractive oncology target due to its role in regulating genes that control cell cycle progression and cellular senescence. Amplification of the KAT6A gene has been seen among patients with worse clinical outcome in ER+ breast cancers. Although multiple inhibitors have been reported, no KAT6 inhibitors have been approved to date. Here, we report the fragment-based discovery of a series of N-(1-phenyl-1H-1,2,3-triazol-4-yl)benzenesulfonamide KAT6 inhibitors and early hit-to-lead efforts to improve the KAT6 potency.

Legend

Protein

Chemical

Disease

Primary Citation of related structures